Guideline document

Your browser can't display PDFs inline. Open the guideline in a new tab.

This guideline is provided for in-page reading only. Please contact the publishing organization for downloadable copies.

17 Views
0 Likes
0 Shares
0 Comments

StayCurrentMD

View profile →

Clinical Guideline

Neuroblastoma PDQ®

Topic overview

Comprehensive NCI clinical reference for healthcare professionals managing neuroblastoma, the most common extracranial solid tumor in children. Covers evidence-based treatment protocols including risk-based stratification, multimodal therapy approaches with surgery, chemotherapy, radiation, and immunotherapy, plus prognostic factors and current clinical trial information.

Key Takeaways

  • Neuroblastoma is the most common extracranial solid tumor in children, often presenting with abdominal mass or metastatic disease.
  • Risk stratification uses age, stage, MYCN amplification, and histology to guide treatment intensity from observation to multimodal therapy.
  • High-risk disease requires intensive chemotherapy, surgery, radiation, stem cell transplant, and immunotherapy for optimal outcomes.
  • Infants with localized disease may have spontaneous regression; observation alone is appropriate for select low-risk patients.
  • Long-term surveillance is essential due to risks of recurrence, secondary malignancies, and treatment-related late effects.

Keywords

Hashtags

Full guideline text

Full text not available for this guideline
How to cite: GlobalCastMD. Neuroblastoma PDQ®. GlobalCastMD Medical Library. https://library.globalcastmd.com/guideline/2381

Comments

Loading comments...